.jpg)
.png)
NLA News
MIAMI, Fla. – (May 18, 2019) -- Clinical lipidology’s best and brightest up-and-comers have been singled out for their exceptional abstracts at the National Lipid Association’s (NLA) 2019 Scientific Sessions, taking place May 16 – 19 in Miami. Five Young Investigator Abstract Award Winners were... more
Be sure to make plans to join us in June (VIRTUALLY) and September (IN-PERSON) for our premier educational events in 2021: Summer of Lipids: A Virtual Education Experience with the NLA · June 4-6, 2021 Our June education experience will feature 3 full days of live,... more
From Cardiovascular Business: By Candace Stuart The National Lipid Association (NLA) published recommendations that are designed to help fill the gaps in the 2013 cholesterol guidelines jointly released by two cardiology associations. The report aligns with some aspects of the guidelines but... more
On December 19, 2024, Ionis Pharmaceuticals, Inc. received FDA approval for TRYNGOLZA (Olezarsen) as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), a rare, genetic form of severe hypertriglyceridemia (sHTG) that can lead to potentially... more
The 2014 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw another increase — from 3.587 (2013) to 3.904 (2014). The Journal is now ranked 44th out of 254 journals in its category (pharmacology and pharmacy). The Thomson-... more
JACKSONVILLE, FL -- (Marketwired - August 29, 2016) - A new study shows that muscle pain and weakness, already common enough in patients taking statins -- the most widely used cholesterol-lowering medications -- appear to be even more common in patients with metabolic syndrome (... more
Chicago-area cardiologist assumes role during NLA Scientific Sessions in Las Vegas JACKSONVILLE, Fla. — Alan S. Brown, MD, FNLA, officially assumed the role of National Lipid Association (NLA) President at the annual Scientific Sessions in Las Vegas on Sunday after serving for the past year... more
We’re pleased to announce that posters presented at the 2019 National Lipid Association (NLA) Scientific Sessions are now available for viewing online! The NLA accepted over 85 abstracts covering topics across the spectrum of clinical lipidology and cardiovascular disease prevention. This... more
JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 -- The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical Communications, LLC (Paradigm), a multiple award-winning medical education company, are proud to announce their... more
By Carl E. Orringer A 55-year-old South Asian Indian physician comes to you for management recommendations for primary prevention of atherosclerotic cardiovascular disease (ASCVD). He has no current cardiovascular symptoms. He has an eight-year history of well-controlled arterial hypertension... more